REGN20934
/ Regeneron
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 08, 2026
Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
(clinicaltrials.gov)
- P1 | N=90 | Recruiting | Sponsor: Regeneron Pharmaceuticals | Not yet recruiting ➔ Recruiting
Enrollment open • Genetic Disorders • Obesity
May 19, 2026
Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
(clinicaltrials.gov)
- P1 | N=90 | Not yet recruiting | Sponsor: Regeneron Pharmaceuticals
New P1 trial • Genetic Disorders • Obesity
1 to 2
Of
2
Go to page
1